Effects of Immunotherapy Clinical Trials

21 clinical trials for Effects of Immunotherapy across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Clinical Study on TIL for the Treatment of Advanced Solid Tumors — RECRUITING · PHASE1
• Impact of Gonadotoxic Therapies on Fertility — RECRUITING
• A Study of TIL in Advanced Solid Tumors (DFGD) — RECRUITING · PHASE1
• A Study of GC101 TIL in Advanced Melanoma (10hospital) — RECRUITING · PHASE1
• A Study of GC101 TIL in Advanced Breast Cancer (10hospital) — RECRUITING · PHASE1
• A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital) — RECRUITING · PHASE1
• A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital) — RECRUITING · PHASE1
• A Study of GC203 TIL in Advanced Gynecologic Tumors (10hospital) — COMPLETED · PHASE1
• Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma — COMPLETED · PHASE1
• Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer — COMPLETED · PHASE1
• Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma — COMPLETED · PHASE2
• Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma — COMPLETED · PHASE1
• TIL and Anti-PD1 in Metastatic Melanoma — OTHER · PHASE1
• Serum MicroRNAs 223 and 146a in Allergic Rhinitis Patients as Biomarkers for Efficacy of Sublingual Immunotherapy — COMPLETED · PHASE3
• Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC — OTHER
• Effect of Sublingual Immunotherapy in Patients With Atopic Dermatitis — COMPLETED · PHASE4
• Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma — COMPLETED · PHASE1
• SCH708980 With and Without AmBisome for Visceral Leishmaniasis — WITHDRAWN · PHASE1
• Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia — OTHER · PHASE1
• Quality of Life and Health Economic Measurements in Allergic Patients Treated With Immunotherapy — COMPLETED
• Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children — COMPLETED · NA

Refine this search